In the process, the PARP inhibitors block PARP function of repairing single-strand breaks and cause the formation of double-strand break upon replication, which cannot be repaired by homologous recombination due to the defected BRCA1/2 function leading to the death of cancer cells [7,8,9,10,11]. Here, BRCA1 is linked to cancer.